No results for ‘’
MPS Pharmaa Ltd
₹1.81
(0%)
Fri, 03 Jul 2026, 11:06 pm
Health Technology
Pharmaceuticals: Major
24.5KMPS Pharmaa EV/EBITDA Ratio
No Result Found
| Particulars |
|---|
| No Result Found |
MPS Pharmaa Ltd Enterprise Value to EBITDA Ratio
The MPS Pharmaa Ltd Enterprise Value to EBITDA Ratio is a key financial metric used by investors to evaluate MPS Pharmaa Ltd's valuation, profitability, and overall financial performance. Tracking the MPS Pharmaa Ltd Enterprise Value to EBITDA Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
MPS Pharmaa Ltd (NSE: , BSE: 531686) is currently trading at ₹1.81, with a market capitalization of ₹3.46Cr. As a leading company in the Health technology sector and Pharmaceuticals: major industry, monitoring the MPS Pharmaa Ltd Enterprise Value to EBITDA Ratio is essential for fundamental analysis.
MPS Pharmaa Ltd Enterprise Value to EBITDA Ratio Current Value
The current MPS Pharmaa Ltd Enterprise Value to EBITDA Ratio stands at 0.
The MPS Pharmaa Ltd Enterprise Value to EBITDA Ratio remains stable, indicating consistent financial performance.
MPS Pharmaa Ltd Enterprise Value to EBITDA Ratio Historical Trend
The MPS Pharmaa Ltd Enterprise Value to EBITDA Ratio has shown the following historical trend:
The decline in MPS Pharmaa Ltd Enterprise Value to EBITDA Ratio indicates improving financial efficiency or better earnings growth.
What MPS Pharmaa Ltd Enterprise Value to EBITDA Ratio Indicates for Investors
The MPS Pharmaa Ltd Enterprise Value to EBITDA Ratio plays a crucial role in understanding the company's financial health and valuation.
This ratio is an important metric used in fundamental analysis of MPS Pharmaa Ltd.
MPS Pharmaa Ltd Enterprise Value to EBITDA Ratio Analysis Summary
The MPS Pharmaa Ltd Enterprise Value to EBITDA Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking MPS Pharmaa Ltd Enterprise Value to EBITDA Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of MPS Pharmaa Ltd Enterprise Value to EBITDA Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.